Toggle Offcanvas
...
 
Candesartan Tenders

Candesartan Tenders

View Candesartan tenders, RFPs and contracts. Bid on readily available Candesartan tenders with the best and most comprehensive tendering platform, since 2002.
Candesartan is an angiotensin receptor blocker ARB used to treat high blood pressure and heart failure. It works by relaxing blood vessels, making it easier for the heart to pump blood.

Bidding for Candesartan tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Candesartan.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Candesartan market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Candesartan tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

9 Live Notices for Candesartan Tenders

Showing 1 to 9

​Item 1 - Candesartan Cilexetil 8mg Tablets Item 2 - Candesartan Cilexetil 16mg Tablets Item 3 - Triamcinolone Acetonide 0.1% w/w and Lidocaine Hydrochloride 3% w/w Dental Paste, 5g tube Item 4 - Fusidic Acid 1% w/v Eye Drops, 5g tube
country Singapore
posting date28 May 2025
deadline30 May 2025
​Item 1 - Candesartan Cilexetil 8mg Tablets Item 2 - Candesartan Cilexetil 16mg Tablets Item 3 - Triamcinolone Acetonide 0.1% w/w and Lidocaine Hydrochloride 3% w/w Dental Paste, 5g tube Item 4 - Fusidic Acid 1% w/v Eye Drops, 5g tube
country Singapore
posting date12 May 2025
deadline30 May 2025
​Item 1 - Candesartan Cilexetil 8mg Tablets Item 2 - Candesartan Cilexetil 16mg Tablets Item 3 - Triamcinolone Acetonide 0.1% w/w and Lidocaine Hydrochloride 3% w/w Dental Paste, 5g tube Item 4 - Fusidic Acid 1% w/v Eye Drops, 5g tube
country Singapore
posting date10 May 2025
deadline30 May 2025
Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V For Combination Products From 01.05.2025
country Germany
posting date08 Apr 2025
deadline10 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
country Germany
posting date31 Oct 2024
deadline31 Dec 2026
Gidroxilethyl -Strochmal D/Inf Fl 6% 200Ml (56303)
country Uzbekistan
posting date15 May 2025
deadline15 May 2026
Bashark 32 Mg
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Children Of The Tum Of The Help 21.04.2025
country Uzbekistan
posting date21 Apr 2025
deadline21 Apr 2026
Children Of The Tum Of The Help 21.04.2025
country Uzbekistan
posting date21 Apr 2025
deadline21 Apr 2026

Share Share this page